- 2,902 views
Kenyans can now access cancer treatment services at a much cheaper cost after Kenyatta University Teaching Research and Referral Hospital- KUTRRH, received a cancer treatment machine from the U.S the machine, cybernife, will facilitate painless non-invasive procedures on prostrate, liver, lung, breast and brain cancers among others. The equipment will be launched end of November. KUTRRH management board chairperson Professor Olive Mugenda announced Kenyans will receive the services at 350,000 to be covered fully by NHIF. Kenya is reportedly the second African country to have received this cancer treatment equipment after Egypt.
Kenyatta University hospital receives Cyberknife cancer treatment machine from the US
- 16 Jul 2025 - Police from Kilifi Police have nabbed a suspected drug trafficker following a tip from members of the public from Kibaoni area in Kilifi Sub-County. Acting on the tip, they launched a swift operation and laid out an ambush and successfully managed to…
- 16 Jul 2025 - The deported men are nationals of Vietnam, Laos, Yemen, Cuba and Jamaica.
- 16 Jul 2025 - The misappropriation was revealed by the Auditor General.
- 16 Jul 2025 - Malala ordered to pay UDA, Mbarire Sh305,000 in legal costs
- 16 Jul 2025 - The teacher is on the spot with multiple institutions calling for his arrest.
- 16 Jul 2025 - Isiolo MCAs agree to work with Guyo after failed impeachment
- 16 Jul 2025 - The infant had their the left eye removed, burn-like injuries on the right foot, complete skin removal from the left foot, facial swelling, and signs of strangulation, which was identified as the cause of death.
- 16 Jul 2025 - He said Nyoro's objections might be influenced by his recent transition from the committee leadership
- 16 Jul 2025 - Sofapaka Football Club Chief Executive Officer Ronald Okoth has officially stepped down from his position following the expiry of his contract. In a statement on Wednesday, July 16, 2025, Okoth expressed his deep gratitude to the club’s leadership,…
- 16 Jul 2025 - Lenacapavir is a long-acting antiretroviral drug that works differently from existing HIV medications